Octagon Capital Advisors LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
OC Octagon Capital Advisors LP | Institutional Filer | ▲ 13.12% | $903.6M | 29 |
Current Portfolio Holdings
Showing all 29 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 1.9M | $163.4M | 18.08% |
| 2 | COGT | Cogent Biosciences, Inc. | Healthcare | 2.4M | $90.5M | 10.01% |
| 3 | ABVX | Abivax S.A. | Healthcare | 677K | $75.4M | 8.34% |
| 4 | ALMS | Alumis Inc. Common Stock | Healthcare | 2.8M | $62.4M | 6.90% |
| 5 | DFTX | DEFINIUM THERAPEUTICS INC | — | 2.4M | $46.1M | 5.10% |
| 6 | AVBP | ArriVent BioPharma, Inc. Common Stock | Healthcare | 2.0M | $45.5M | 5.03% |
| 7 | TSHA | Taysha Gene Therapies, Inc. | Healthcare | 8.9M | $39.6M | 4.38% |
| 8 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 425K | $35.4M | 3.92% |
| 9 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 339K | $31.3M | 3.46% |
| 10 | BIOA | BioAge Labs, Inc. | Healthcare | 1.7M | $30.6M | 3.38% |
| 11 | CNTA | Centessa Pharmaceuticals plc | Healthcare | 750K | $29.8M | 3.30% |
| 12 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 1.4M | $29.2M | 3.23% |
| 13 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 490K | $28.5M | 3.15% |
| 14 | TERN | Terns Pharmaceuticals, Inc. | Healthcare | 530K | $27.9M | 3.09% |
| 15 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 3.2M | $26.8M | 2.97% |
Showing 1 to 15 of 29 holdings